Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-SLV187 Monotherapy in Advanced Parkinson's Disease With Motor Complications
jRCT2080222381Phase 3
- Sponsor
- AbbVie Inc.
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levodopa + carbidopa in Parkinson's disease (PD), sponsored by AbbVie Inc.
02
Drugs
levodopa + carbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080222381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222381.